Details for New Drug Application (NDA): 083247
✉ Email this page to a colleague
NDA 083247 describes NEMBUTAL, which is a drug marketed by Sciegen Pharms Inc, Epic Pharma Llc, and Rising, and is included in six NDAs. Additional details are available on the NEMBUTAL profile page.
The generic ingredient in NEMBUTAL is pentobarbital sodium. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the pentobarbital sodium profile page.
The generic ingredient in NEMBUTAL is pentobarbital sodium. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the pentobarbital sodium profile page.
Summary for 083247
| Tradename: | NEMBUTAL |
| Applicant: | Sciegen Pharms Inc |
| Ingredient: | pentobarbital sodium |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUPPOSITORY;RECTAL | Strength | 30MG | ||||
| Approval Date: | Jan 25, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUPPOSITORY;RECTAL | Strength | 60MG | ||||
| Approval Date: | Jan 25, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUPPOSITORY;RECTAL | Strength | 120MG | ||||
| Approval Date: | Jan 25, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
